These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8295602)

  • 41. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
    Hreybe H; Ezzeddine R; Barrington W; Bazaz R; Jain S; Ngwu O; Saba S
    Am J Cardiol; 2006 Feb; 97(4):544-6. PubMed ID: 16461053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acceptance and quality of life after implantation of an automatic cardioverter/defibrillator].
    Schöhl W; Trappe HJ; Lichtlen PR
    Z Kardiol; 1994 Dec; 83(12):927-32. PubMed ID: 7846932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD.
    Corzani A; Ziacchi M; Biffi M; Diemberger I; Martignani C; Boriani G
    Indian Heart J; 2015; 67(1):56-9. PubMed ID: 25820052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inappropriate implantable cardioverter-defibrillator shocks due to temporary epicardial pacing.
    Gelissen M; Debie L; van Opstal J
    Europace; 2010 Nov; 12(11):1648. PubMed ID: 20543194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials.
    Peters RW; Cooklin M; Brockman R; Shorofsky SR; Gold MR
    J Interv Card Electrophysiol; 1998 Dec; 2(4):367-70. PubMed ID: 10027123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure.
    Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y
    Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transvenous defibrillator systems implanted by electrophysiologists in the catheterization laboratory.
    Manolis AS; Vassilikos V; Maounis T; Chiladakis J; Cokkinos DV
    Clin Cardiol; 1997 Feb; 20(2):117-24. PubMed ID: 9034640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complications of third-generation implantable cardioverter defibrillator therapy.
    Grimm W; Menz V; Hoffmann J; Timmann U; Funck R; Moosdorf R; Maisch B
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):206-11. PubMed ID: 9990632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Defibrillator therapy 1997. Prerequisites--results--prospects].
    Trappe HJ
    Med Klin (Munich); 1997 Jul; 92(7):415-20. PubMed ID: 9324627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sub-pectoral implantation of defibrillators: intraoperative data and long-term outcome].
    Hief C; Podczeck A; Frohner K; Nürnberg M; Veit F; Steinbach K
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):491-5. PubMed ID: 9746963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous implantable cardioverter-defibrillator technology.
    Gupta A; Al-Ahmad A; Wang PJ
    Heart Fail Clin; 2011 Apr; 7(2):287-94, x. PubMed ID: 21439506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of inefficient defibrillation during thoracotomy.
    Sponga S; Mascioli G; Voisine P; Vitali E
    J Card Surg; 2011 May; 26(3):338-9. PubMed ID: 21231961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lead-related complications in 340 patients with an implantable cardiverter/defibrillator].
    Schwacke H; Drögemüller A; Siemon G; Werling C; Saggau W; Senges J; Seidl K
    Z Kardiol; 1999 Aug; 88(8):559-65. PubMed ID: 10506392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensing lead insulation fractures following implantable cardioverter-defibrillator placement.
    Tedder M; Anstadt MP; Tedder SD; Revishvili AS; Hegde SS; Lowe JE
    ASAIO J; 1993; 39(3):M711-4. PubMed ID: 8268630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Results of testing defibrillator function of implanted cardioverter/defibrillators].
    Brunn J; Block M; Weber M; Bänsch D; Seifert T; Castrucci M; Isbruch F; Böcker D; Breithardt G
    Z Kardiol; 1997 Jun; 86(6):450-9. PubMed ID: 9324876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantation of a fully subcutaneous ICD in children.
    McLeod KA; McLean A
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):e20-3. PubMed ID: 20723088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oversensing in a cardioverter defibrillator system caused by interaction between two endocardial defibrillation leads in the right ventricle.
    Pfitzner P; Trappe HJ
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):764-8. PubMed ID: 9584310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.